Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome

NCT02879578 is registered in ClinicalTrials.gov with Neurocrine Biosciences as lead sponsor.

NCT NCT02879578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02879578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Tolerability Study of NBI-98854 for the Treatment of Subjects With Tourette Syndrome
Lead sponsor
Neurocrine Biosciences
Phase
Phase 2
Overall status
Completed
Start date
July 25, 2016
Completion date
November 1, 2017
Enrollment
155 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

tourette syndrome